Beginning May 4, 2009, all manuscripts should be submitted to the Web site address http://ees.elsevier.com/cgc/.
In addition to full-length research papers, short communications (less than 3,000 words), and letters to the editor (less than 1,500
words, one table and one figure, or one of each, and a maximum of 10 references) may be submitted. Review articles, editorials, and special
articles may also be published from time to time by invitation or arrangement with the Editor-in-Chief. Book reviews will be published
as conditions permit. Manuscripts are submitted with the understanding that they present original unpublished work and are not being
submitted elsewhere.
Manuscript. All manuscripts (except for letters-to-the-editor) should include the following sections:
Abstract (up to 200 words), Introduction, Materials and Methods, Results, Discussion, Acknowledgements (optional), References, and Figure
legends. The title page should include the paper's title, names of all authors (no degrees), and their academic or professional affiliations.
Superscript letters in alphabetical order should designate each author to the corresponding affiliation. An asterisk should be placed
after the superscript letter to designate the corresponding author. The affiliation of the corresponding author, given on a footnote,
should include a complete address with street name and number, telephone and fax numbers and e-mail address of corresponding author.
All tables, numbered with Arabic numerals, should have descriptive titles. Use vertical rules only. Use superscript letters in alphabetical
order in the table footnote section. Authors not fluent in the English language should have their manuscript edited by an expert in
the language prior to submission to the journal, thus avoiding delays in the review and publication of their paper.
The journal
will primarily follow the cytogenetics nomenclature of the latest version of the International System of the Human Cytogenetic Nomenclature
(ISCN 2009). One exception to ISCN is to use a hyphen (-) instead of a tilde (˜) when a break occurs between separate
bands. (This exception, which is only applicable to the title and abstract, is necessary because some abstracting and indexing databases,
including PubMed, do not support the tilde (˜).) Human genes, mRNA and cDNA symbols should be named according to HUGO
and written in italicized capital letters (e.g. TP53, BCR-ABL1); proteins should be written in capital letters but not italicized
(P53, BCR); and probe names should be written in capital letters not italicized. When referring to the probe itself, please use name
provided by manufacturer (e.g. TEL/AML1, AML1/ETO); however the FISH nomenclature should be written using the gene symbols according
to HUGO.
All abbreviations should be defined when first used. Authors seeking information about the status of their accepted paper can
log-in at http://www.elsevier.com/authors (the reference number needed to track the paper will be sent by Elsevier, as
soon as the galley proofs are completed).
Revised manuscript. A letter listing the revisions made, together with a complete
copy of the revised text and pictorial material should be sent submitted electronically at the Web site address http://ees.elsevier.com/cgc.
Changes suggested by the reviewers and not made by the authors should be justified.
Illustrations. Electronic art can be submitted
as EPS, JPG, PDF, TIFF, or Postscript. Authors must label in black (solid numbers should be used) the chromosomes on the karyotype using
arrows to indicate the abnormal chromosome(s). Authors are encouraged to refrain from using annotations within the karyotype itself and
include these in the appropriate legend. The legend to the figures must be typed on a separate page. The legend must match the information
presented in the corresponding picture. For more information on submission guidelines for figures, visit http://www.elsevier.com/artworkinstructions.
Color art. Upon submission of the manuscript, authors must provide a letter agreeing to pay for the publication of figures
with color. Once the article is accepted for publication, the exact charge will be determined by the publisher and an agreement e-mailed
or faxed in the form of a PDF file. As a guideline, there is a $650 charge for the first color picture and $100 for every
additional color picture in the article. Color artwork will appear in color on the web site at no charge.
References. Authors
are responsible for the completeness and accuracy of all references (use et al. for references that have more than 6 authors). References
are to be listed and numbered consecutively in the order in which they are cited in the text. Citations in the text are listed consecutively
using numbers in brackets, i.e. [1], or [2, 3], or [4-6]. Periodical abbreviations should follow those given by Index Medicus. Samples
of reference styles are given below:
Journal: [1] Tirado CA, Meloni-Ehrig AM, Edwards T, Scheerle J, Burks K, Repetti C,
et al. Cryptic ins(4;11)(q21;q23q23) detected by
fluorescence in situ hybridization: a variant of t(4;11)(q21;q23) in an infant with
a precursor B-cell acute lymphoblastic leukemia; report of
a second case. Cancer Genet Cytogenet 2007;174:166-9.
Book:
[2] Sandberg AA, Stone JA. Cytogenetics and molecular biology of neural tumors. Austin: RG Landes Co., 2008.
Edited book:
[3] Schaffer LG, Tommerup N, editors. ISCN: an international system for human cytogenetic nomenclature. Basel: S. Karger, 2005.
Chapter:
[4] Sandberg AA, Chen Z. Cancer cytogenetics: nomenclature and clinical applications. In: Kurzrock R, Talpaz M, editors. Molecular biology
in cancer medicine. London: Martin Dunits Ltd. 1995; pp.54-84.
Proofs
and reprints. The corresponding author will receive proofs via e-mail in PDF format, containing comments and queries from the reviewers
and editors that should be addressed. An explanation should be given for those areas not addressed by the authors. The corrected proofs
should be returned within 48 hours of receipt.
Copyright. Upon acceptance of an article by the journal, the authors
will be asked to transfer copyright of the article to the publisher. This transfer form is to be signed and returned to the publisher
at the address shown on the form, which will ensure the widest possible dissemination of information under the U.S. Copyright Law.
Editors e-mail addresses:
Avery A. Sandberg, M.D., D.Sc., Editor-in-Chief: aascgc@cox.net;
